Van-Telmisartan-HCTZ: Uses, Side Effects and Dosage

ABOUT THIS MEDICATION

What the medication is used for:

VAN-Telmisartan-HCTZ Tablets are a combination of 2 drugs. It is used when 2 drugs are required to treat your high blood pressure.

What it does:

VAN-Telmisartan-HCTZ Tablets contain a combination of 2 drugs, telmisartan and hydrochlorothiazide:

• Telmisartan is an angiotensin receptor blocker (ARB).

  You can recognize an ARB because its medicinal ingredient ends in “-SARTAN”. It lowers blood pressure.

• Hydrochlorothiazide is a diuretic or “water pill” that

  increases urination. This lowers blood pressure.

This medicine does not cure high blood pressure. It helps to control it. Therefore, it is important to continue taking VAN-Telmisartan-HCTZ Tablets regularly even if you feel fine.

When it should not be used:

Do not take VAN-Telmisartan-HCTZ Tablets if you:

• Are allergic to telmisartan, hydrochlorothiazide or to

  any nonmedical ingredient in the formulation.

• Are allergic to any sulfonamide-derived drugs (sulfa

  drugs), most of them have a medicinal ingredient that ends in “-MIDE”. This includes other diuretics (“water pills”).

• Have experienced an allergic reaction (angioedema)

  with swelling of the hands, feet or ankles, face, lips, tongue, throat, or sudden difficulty breathing or swallowing to any ARB (any drug in the same class as telmisartan tablets). Be sure to tell your doctor, nurse, or pharmacist that this has happened to you.

• Have difficulty urinating or produce no urine.

• Are pregnant or intend to become pregnant. Taking

  VAN-Telmisartan-HCTZ Tablets during pregnancy can cause injury and even death to your baby.

• Are breastfeeding. VAN-Telmisartan-HCTZ Tablets

  pass into breast milk.

  • Are allergic to some sugars (fructose, lactose and/or mannitol).
  • Are already taking a blood pressure-lowering medicine that contains aliskiren (such as Rasilez) and you have diabetes or kidney disease.

  • Have one of the following rare hereditary diseases:

    o Galactose intolerance;

    o Lapp lactase deficiency;

    o Glucose-galactose malabsorption.

Because lactose is a non-medicinal ingredient in VAN-Telmisartan-HCTZ Tablets.

What the medicinal ingredients are:

Telmisartan and hydrochlorothiazide

What the non-medicinal ingredients are:

Iron oxide red (for the 80 mg/12.5 mg tablet only), iron oxide yellow (for the 80 mg/25 mg tablet only), lactose monohydrate, magnesium stearate, maize starch, mannitol, meglumine, microcrystalline cellulose, povidone, and sodium hydroxide

What dosage forms it comes in:

Tablets 80 mg/12.5 mg and 80 mg/25 mg.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions – Pregnancy

VAN-Telmisartan-HCTZ Tablets should not be used during pregnancy. If you discover that you are pregnant while taking VAN-Telmisartan-HCTZ Tablets, stop the medication and contact your doctor, nurse or pharmacist as soon as possible.

Before you use VAN-Telmisartan-HCTZ Tablets, talk to your doctor, nurse or pharmacist if you:

• Are allergic to any drug used to lower blood pressure including angiotensin converting enzyme (ACE) inhibitors, or penicillin.
• Have narrowing of an artery or a heart valve.
• Have heart failure.
• Have diabetes, liver or kidney disease.

• Are taking a medicine that contains aliskiren, such as

  Rasilez, used to lower high blood pressure. The combination with VAN-Telmisartan-HCTZ Tablets is not recommended.

• Are taking an angiotensin-converting-enzyme inhibitor (ACEI).
• Have lupus or gout.
• Are on dialysis.

• Are dehydrated or if you suffer from excessive

  vomiting, diarrhea, or sweating.

• Are taking a salt substitute that contains potassium,

  potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill”).

• Are on a low-salt diet.
• Are less than 18 years old.

• Are having surgery and general anesthesia, (even at

  the dentist's office), tell the doctor or dentist that you are taking VAN-Telmisartan-HCTZ Tablets as there may be a sudden fall in blood pressure associated with general anesthesia.

• Have been told by your doctor that you have an

  intolerance to some sugars.

Hydrochlorothiazide in VAN-Telmisartan-HCTZ Tablets can cause Sudden Eye Disorders:

• Myopia: sudden nearsightedness or blurred vision.

• Glaucoma: an increased pressure in your eyes, eye

  pain. Untreated, it may lead to permanent vision loss. These eye disorders are related and can develop within hours to weeks of starting VAN-Telmisartan-HCTZ Tablets.

You may become sensitive to the sun while taking VAN-Telmisartan-HCTZ Tablets. Exposure to sunlight should be minimized until you know how you respond.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to VAN-Telmisartan-HCTZ Tablets. Dizziness, lightheadedness, or fainting can especially occur after the first dose and when the dose is increased

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with VAN-Telmisartan-HCTZ Tablets:

• Adrenocorticotropic hormone (ACTH) used to treat

  West Syndrome.

• Alcohol, barbiturates (sleeping pills), or narcotics

  (strong pain medications). They may cause low blood pressure and dizziness when you go from lying or sitting to standing up.

• Amphotericin B, an antifungal drug.

• Anticancer drugs, including cyclophosphamide and

  methotrexate.

• Antidepressants, in particular selective serotonin

  reuptake inhibitors (SSRIs), including citalopram, escitalopram, and sertraline.

  • Antidiabetic drugs, including insulin and oral medicines.

  • Bile acid resins used to lower cholesterol, such as

    Cholestyramine and Colestipol Resins.

  • Other blood pressure lowering drugs, including diuretics (“water pills”), aliskiren-containing products (e.g. Rasilez), or angiotension-converting-enzyme inhibitors (ACEI). When taken in combination with VAN-Telmisartan-HCTZ Tablets, they may cause excessively low blood pressure.
  • Calcium or vitamin D supplements.
  • Corticosteroids used to treat joint pain and swelling.
  • Digoxin, a heart medication.
  • Drugs that slow down or speed up bowel function, including atropine, metoclopramide, and domperidone.
  • Drugs used to treat epilepsy, including carbamazepine and topiramate.
  • Gout medications, including allopurinol and probenecid.
  • Lithium used to treat bipolar disease.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), used to reduce pain and swelling. Examples include ibuprofen, naproxen, and celecoxib.
  • Skeletal muscle relaxants used to relieve muscle spasms, including tubocurare.
  • Pressor Amines (e.g. norepinephrine)
  • Warfarin.

PROPER USE OF THIS MEDICATION

Take VAN-Telmisartan-HCTZ Tablets exactly as prescribed. It is recommended to take your dose at about the same time everyday preferably in the morning.

VAN-Telmisartan-HCTZ Tablets can be taken with or without food, but it should be taken the same way each day. If VAN-Telmisartan-HCTZ Tablets cause upset stomach, take it with food or milk.

Usual adult dose:

The recommended dose of VAN-Telmisartan-HCTZ Tablets is one tablet daily.

Overdose:

If you think you have taken too much VAN-Telmisartan-HCTZ Tablets contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

• back or leg pain, muscle cramps, joint pain, muscle spasms, pain, weakness, restlessness
• headache, anxiety, dizziness, pins and needles in your fingers
• diarrhea, constipation, nausea, vomiting, upset stomach, abdominal pain, flatulence , decreased appetite, enlargement of the glands in your mouth
• dry mouth
• rash, eczema, skin eruptions, bleeding under the skin, red patches on the skin
• drowsiness, insomnia, fatigue
• visual disturbances
• upper respiratory infection
• reduced libido

If any of these affects you severely, tell your doctor, nurse or pharmacist.

VAN-Telmisartan-HCTZ Tablets can cause abnormal blood test results.

Your doctor will decide when to perform blood tests and will interpret the results.

This is not a complete list of side effects. For any unexpected effects while taking VAN-Telmisartan-HCTZ Tablets, contact your doctor or pharmacist.

HOW TO STORE IT

Store VAN-Telmisartan-HCTZ Tablets at room temperature (15 to 30 ºC) in the package provided by your doctor or pharmacist and protect from excessive moisture. Do not remove tablets from blisters until immediately prior to administration.

Store VAN-Telmisartan-HCTZ Tablets out of the reach of children and pets.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

-----------------------------------------------------------------------

• Report online at www.healthcanada.gc.ca/medeffect
• Call toll-free at 1-866-234-2345

• Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or

  • Mail to: Canada Vigilance Program

    Health Canada

    Postal Locator 0701E

    Ottawa, Ontario

    K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect^TM Canada Web site at

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional.

The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting at:

Manufacturer and Distributor:

Vanc Pharmaceuticals Inc. Building 152, 11782 River Road

Richmond, BC V6X 1Z7

www.vancpharm.com

Last revised: November 7, 2014